One-year cardiovascular outcomes after coronavirus disease 2019: The cardiovascular COVID-19 registry
Fig 3
Cumulative incidence of arterial thrombotic events and venous thromboembolism in the COVID-19 and control cohorts.
Cumulative 1-year incidences are shown with Kaplan-Meier event rates with 95% CI. (A1 and B1) Entire study comprised from 0–365 days and (A2 and B2) post-acute phase from 31–365 days. Adj HR, adjusted hazard ratio; 95%CI, 95% confidence interval.